Biotech Partners

Analysis

Biotech Partners is a registered charity in United States, based in Emeryville, CA. It received its IRS tax-exemption ruling in September 1993, 33 years ago. Its declared purposes cover education, which this site groups under education and training. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Biotech Partners reported income of $1.7m and spending of $1.1m, leaving 34% of income unspent that year. Across the 5 years on record, from December 2019 to December 2023, income grew from $791k to $1.7m (+110%), an average of +20% a year. The sharpest change came in the year to December 2020, when income rose by 43%. Over the whole period it spent 83% of the income it received.

Among 66,972 United States charities whose main cause is education and training and that reported income, Biotech Partners sits at the 81st percentile: it is larger than about 80% of them. Against every charity in United States with reported income it ranks in the 84th percentile, and in the 85th percentile within CA. Charities of a similar size with the same main cause include Residential Revival Indiana ($1.7m), University of Florida College of Pharmacy Faculty Practice Assoc in ($1.7m) and Wildflower New York Charter School ($1.7m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 100% of the total. Compensation of current officers, directors and key employees was $150k (14% of expenses). Other salaries and wages came to $365k. At year end it held assets of $1.3m against liabilities of $224k, net assets of $1.0m. It reported 12 employees.